The catechol-O-methyl-transferase gene in tardive dyskinesia

Authors:
  • ATArun K. Tiwari
    Arun K. Tiwari
  • DMDaniel J. Müller
    Daniel J. Müller
  • VLVincenzo de Luca
    Vincenzo de Luca
  • TSTakahiro Shinkai
    Takahiro Shinkai
  • SSSajid Shaikh
    Sajid Shaikh
  • XNXingqun Ni
    Xingqun Ni
  • DSDavid Sibony
    David Sibony
  • AVAristotle N. Voineskos
    Aristotle N. Voineskos
  • HMHerbert Y. Meltzer
    Herbert Y. Meltzer
  • JLJeffrey A. Lieberman
    Jeffrey A. Lieberman

Abstract
Tardive dyskinesia (TD) is a severe and potentially irreversible motor side effect linked to long-term antipsychotic exposure. Changes in dopamine neurotransmission have been implicated in the etiology of TD, and catechol-O-methyl-transferase (COMT) is an enzyme that metabolizes dopamine. We investigated five single-nucleotide polymorphisms in addition to the functional Val158Met variant spanning the COMT gene for association with TD. We analyzed the six COMT single-nucleotide polymorphisms in a sample of schizophrenia/schizoaffective disorder patients (n=226; 196 Caucasians and 30 African Americans). We found a significant association between the marker rs165599 in the 3' untranslated region of COMT and TD (AA versus G-carrier: OR(AA)=2.22, 95% CI:1.23-4.03; P=0.007). The association appeared to be originating from males. We did not find a significant association of the other five tested polymorphisms with TD in our samples. We performed a sex-stratified meta-analysis across all of the published studies (n=6 plus our own data) of COMT and TD, and found an association between ValVal genotype and TD in females (OR(ValVal)=1.63, 95% CI: 1.09-2.45; P=0.019) but not in males. Overall, our results suggest that the COMT gene may have a minor but consistent role in TD, although sex-stratified studies with additional markers in larger clinical samples should be performed.

This publication has 41 references indexed in Scilit: